The trajectory of companies tied to flagship drugs like Viagra presents a challenging investment scenario . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the loss of exclusivity in key markets has introduced substantial volatility. Investors are now assessing the consequences of gen